Literature DB >> 7933372

Limitations and withdrawals of medical intervention in pediatric critical care.

M Levetown1, M M Pollack, T T Cuerdon, U E Ruttimann, J J Glover.   

Abstract

OBJECTIVE: To investigate the use and implementation in pediatric intensive care units (PICUs) of three levels of restriction of medical intervention: do not resuscitate (DNR), additional limitations of medical interventions beyond DNR, and withdrawal of care.
DESIGN: Consecutive patients admitted between December 1989 and January 1992.
SETTING: A total of 16 PICUs randomly selected to represent variability in size, teaching status, and presence or absence of a pediatric intensivist and unit coordination. MAIN OUTCOME MEASURES: Profiles of children undergoing restrictions of medical interventions including the influence of chronic disease, the justifications for restrictions, and description of implementation practices. PATIENTS: All pediatric admissions undergoing restrictions (n = 119) drawn from 5415 consecutive PICU admissions.
RESULTS: A total of 94 (79%) of the restriction patients died during the PICU course, representing 38% of all deaths. A total of 73 restrictions (61%) resulted from acute disease, most involving the central nervous system or respiratory system. Restrictions were evenly divided between DNR (39%), additional limitations of medical intervention beyond DNR (27%), and withdrawals of medical intervention (34%). Survival decreased with increasing levels of restriction from 35% of DNR patients to 9% of patients with additional limitations and 2% of withdrawal patients. Imminent death was cited as the justification for restrictions in 70% of cases, no relational potential was cited in 22%, and excessive burden was cited in 8%.
CONCLUSIONS: Restrictions of medical intervention were used in all PICUs surveyed. Although severe chronic disease was common among restriction patients, acute disease was the predominant event precipitating placement of restrictions. Imminent death, not quality of life or excessive burden, was the most common justification.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach

Mesh:

Year:  1994        PMID: 7933372

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  7 in total

1.  Ethical debate: The distinction between withdrawing life sustaining treatment under the influence of paralysing agents and euthanasia. Are we treading a fine line?

Authors:  K Street; J Henderson
Journal:  BMJ       Date:  2001-08-18

2.  Withdrawal and limitation of life support in paediatric intensive care.

Authors:  A Y Goh; L C Lum; P W Chan; F Bakar; B O Chong
Journal:  Arch Dis Child       Date:  1999-05       Impact factor: 3.791

3.  The decision making process regarding the withdrawal or withholding of potential life-saving treatments in a children's hospital.

Authors:  K Street; R Ashcroft; J Henderson; A V Campbell
Journal:  J Med Ethics       Date:  2000-10       Impact factor: 2.903

4.  Parental views on withdrawing life-sustaining therapies in critically ill children.

Authors:  Kelly Nicole Michelson; Tracy Koogler; Christine Sullivan; María del Pilar Ortega; Emily Hall; Joel Frader
Journal:  Arch Pediatr Adolesc Med       Date:  2009-11

5.  Mortality in very long-stay pediatric intensive care unit patients and incidence of withdrawal of treatment.

Authors:  Sara Naghib; Cynthia van der Starre; Saskia J Gischler; Koen F M Joosten; Dick Tibboel
Journal:  Intensive Care Med       Date:  2009-10-24       Impact factor: 17.440

6.  Epidemiology of death in the PICU at five U.S. teaching hospitals*.

Authors:  Jeffrey P Burns; Deborah E Sellers; Elaine C Meyer; Mithya Lewis-Newby; Robert D Truog
Journal:  Crit Care Med       Date:  2014-09       Impact factor: 7.598

7.  End-of-life care in a pediatric intensive care unit: the impact of the development of a palliative care unit.

Authors:  Sara Bobillo-Perez; Susana Segura; Monica Girona-Alarcon; Aida Felipe; Monica Balaguer; Lluisa Hernandez-Platero; Anna Sole-Ribalta; Carmina Guitart; Iolanda Jordan; Francisco Jose Cambra
Journal:  BMC Palliat Care       Date:  2020-05-28       Impact factor: 3.234

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.